Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Are Late-Stage Deals Beginning to Lose Their Luster?

Jun 01 2004

Related Content

Bioteching UCB-and Maybe Mid-Sized Pharma, Too

Jun 01 2004

Enzon: The Perils of Profitability

Apr 01 2004

Pliva/Indevus: Moving Up the Value Chain

May 01 2004

Related Companies

Merck & Co., Inc.

H. Lundbeck A/S

Pfizer Inc.

Neurocrine Biosciences, Inc.

Merck KGaA

Biogen, Inc.

UCB S.A.

UCB S.A.

NPS Pharmaceuticals, Inc.

Takeda Pharmaceutical Co. Ltd.

Eli Lilly and Company

Endo, Inc.

SkyePharma PLC

Teva Pharmaceutical Industries Ltd.

Forest Laboratories, Inc.

Bristol Myers Squibb Company

Additional Topics

Business Strategies BioPharmaceutical

More from Business Strategy

More from In Vivo

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window